BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu XX, Murray SF, Watts L, Booten SL, Tokorcheck J, Monia BP, Bhanot S. Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice. Am J Physiol Endocrinol Metab. 2008;295:E436-E445. [PMID: 18523126 DOI: 10.1152/ajpendo.00629.2007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Garcia-Garcia J, Guney E, Aragues R, Planas-Iglesias J, Oliva B. Biana: a software framework for compiling biological interactions and analyzing networks. BMC Bioinformatics 2010;11:56. [PMID: 20105306 DOI: 10.1186/1471-2105-11-56] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
2 Crooke RM, Graham MJ. Therapeutic potential of antisense oligonucleotides for the management of dyslipidemia. Clinical Lipidology 2011;6:675-92. [DOI: 10.2217/clp.11.59] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Xue H, Chen D, Zhong Y, Zhou Z, Fang S, Li M, Guo C. Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice. Ann N Y Acad Sci 2016;1375:52-65. [DOI: 10.1111/nyas.13174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
4 Ngoei KR, Ng DC, Gooley PR, Fairlie DP, Stoermer MJ, Bogoyevitch MA. Identification and characterization of bi-thiazole-2,2'-diamines as kinase inhibitory scaffolds. Biochim Biophys Acta 2013;1834:1077-88. [PMID: 23410953 DOI: 10.1016/j.bbapap.2013.02.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Kodama Y, Brenner DA. c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: Multiple roles in multiple steps. Hepatology 2009;49:6-8. [PMID: 19111006 DOI: 10.1002/hep.22710] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
6 Drosatos K, Schulze PC. Cardiac lipotoxicity: molecular pathways and therapeutic implications. Curr Heart Fail Rep 2013;10:109-21. [PMID: 23508767 DOI: 10.1007/s11897-013-0133-0] [Cited by in Crossref: 109] [Cited by in F6Publishing: 104] [Article Influence: 12.1] [Reference Citation Analysis]
7 Rana R, Shearer AM, Fletcher EK, Nguyen N, Guha S, Cox DH, Abdelmalek M, Wang Y, Baleja JD, Covic L, Kuliopulos A. PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease. Mol Metab 2019;29:99-113. [PMID: 31668396 DOI: 10.1016/j.molmet.2019.08.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
8 Tarantino G, Capone D. Inhibition of the mTOR pathway: a possible protective role in coronary artery disease. Ann Med. 2013;45:348-356. [PMID: 23668688 DOI: 10.3109/07853890.2013.770333] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
9 Park YS, David AE, Huang Y, Park JB, He H, Byun Y, Yang VC. In vivo delivery of cell-permeable antisense hypoxia-inducible factor 1α oligonucleotide to adipose tissue reduces adiposity in obese mice. J Control Release 2012;161:1-9. [PMID: 22546680 DOI: 10.1016/j.jconrel.2012.04.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
10 Josekutty J, Iqbal J, Iwawaki T, Kohno K, Hussain MM. Microsomal triglyceride transfer protein inhibition induces endoplasmic reticulum stress and increases gene transcription via Ire1α/cJun to enhance plasma ALT/AST. J Biol Chem 2013;288:14372-83. [PMID: 23532846 DOI: 10.1074/jbc.M113.459602] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
11 Drosatos K, Drosatos-Tampakaki Z, Khan R, Homma S, Schulze PC, Zannis VI, Goldberg IJ. Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction. J Biol Chem 2011;286:36331-9. [PMID: 21873422 DOI: 10.1074/jbc.M111.272146] [Cited by in Crossref: 65] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
12 Czaja MJ. JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol Metab 2010;21:707-13. [PMID: 20888782 DOI: 10.1016/j.tem.2010.08.010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
13 Song XS, Zhang J, Chen X, Palyha O, Chung C, Sonatore LM, Wilsie L, Stout S, Mclaren DG, Taggart A, Imbriglio JE, Pinto S, Garcia-calvo M, Addona GH. Identification of DGAT2 Inhibitors Using Mass Spectrometry. J Biomol Screen 2016;21:117-26. [DOI: 10.1177/1087057115607463] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
14 Tarantino G, Caputi A. JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. World J Gastroenterol 2011; 17(33): 3785-3794 [PMID: 21987620 DOI: 10.3748/wjg.v17.i33.3785] [Cited by in CrossRef: 82] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]
15 Cubero FJ, Drvarov O, Trautwein C, Kowdley K, Mccaughan G, Trautwein C. c-Jun NH2-terminal kinase 1 in hepatocytes: An essential mediator of insulin resistance. Hepatology 2010;51:2221-3. [DOI: 10.1002/hep.23737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Danai LV, Guilherme A, Guntur KV, Straubhaar J, Nicoloro SM, Czech MP. Map4k4 suppresses Srebp-1 and adipocyte lipogenesis independent of JNK signaling. J Lipid Res 2013;54:2697-707. [PMID: 23924694 DOI: 10.1194/jlr.M038802] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
17 Kang S, Kong X, Rosen ED. Adipocyte-specific transgenic and knockout models. Methods Enzymol 2014;537:1-16. [PMID: 24480338 DOI: 10.1016/B978-0-12-411619-1.00001-X] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
18 Garg R, Kumariya S, Katekar R, Verma S, Goand UK, Gayen JR. JNK signaling pathway in metabolic disorders: An emerging therapeutic target. Eur J Pharmacol 2021;901:174079. [PMID: 33812885 DOI: 10.1016/j.ejphar.2021.174079] [Reference Citation Analysis]
19 Cicuéndez B, Ruiz-Garrido I, Mora A, Sabio G. Stress kinases in the development of liver steatosis and hepatocellular carcinoma. Mol Metab 2021;50:101190. [PMID: 33588102 DOI: 10.1016/j.molmet.2021.101190] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Yu XX, Watts LM, Manchem VP, Chakravarty K, Monia BP, McCaleb ML, Bhanot S. Peripheral reduction of FGFR4 with antisense oligonucleotides increases metabolic rate and lowers adiposity in diet-induced obese mice. PLoS One 2013;8:e66923. [PMID: 23922646 DOI: 10.1371/journal.pone.0066923] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
21 Díaz-delfín J, Hondares E, Iglesias R, Giralt M, Caelles C, Villarroya F. TNF-α Represses β-Klotho Expression and Impairs FGF21 Action in Adipose Cells: Involvement of JNK1 in the FGF21 Pathway. Endocrinology 2012;153:4238-45. [DOI: 10.1210/en.2012-1193] [Cited by in Crossref: 129] [Cited by in F6Publishing: 126] [Article Influence: 12.9] [Reference Citation Analysis]
22 Xie, Zhao H, Lu J, He F, Liu W, Yu W, Wang Q, Hisatome I, Yamamoto T, Koyama H, Cheng J. High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling. Am J Physiol Endocrinol Metab 2021;320:E1032-43. [PMID: 33900847 DOI: 10.1152/ajpendo.00518.2020] [Reference Citation Analysis]